IRIS
FAZIOLI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.064
EU - Europa 3.193
AS - Asia 1.809
SA - Sud America 357
AF - Africa 135
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.576
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.961
RU - Federazione Russa 1.574
SG - Singapore 545
VN - Vietnam 426
IT - Italia 375
BR - Brasile 290
CN - Cina 288
UA - Ucraina 266
HK - Hong Kong 201
SE - Svezia 195
DE - Germania 176
IE - Irlanda 148
FR - Francia 105
DK - Danimarca 101
TR - Turchia 94
CI - Costa d'Avorio 89
GB - Regno Unito 81
FI - Finlandia 79
CA - Canada 71
KR - Corea 56
BD - Bangladesh 40
IN - India 33
AR - Argentina 29
MX - Messico 26
NL - Olanda 23
JP - Giappone 21
BE - Belgio 19
ZA - Sudafrica 15
IQ - Iraq 13
CO - Colombia 12
PL - Polonia 12
ID - Indonesia 11
AT - Austria 10
PH - Filippine 10
SA - Arabia Saudita 10
CL - Cile 8
MA - Marocco 8
NZ - Nuova Zelanda 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EC - Ecuador 6
PK - Pakistan 6
UZ - Uzbekistan 6
ES - Italia 5
JO - Giordania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AU - Australia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
OM - Oman 4
TH - Thailandia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.576
Salva come PNG Salva come JPEG
Città #
Dallas 1.479
Ashburn 459
Chandler 351
Singapore 322
Des Moines 289
Jacksonville 265
Hong Kong 189
Boardman 159
San Jose 157
Fairfield 156
Ho Chi Minh City 153
Dublin 148
New York 129
Ann Arbor 119
Hanoi 93
Abidjan 89
Wilmington 88
Houston 86
Woodbridge 84
Beijing 76
The Dalles 69
Los Angeles 66
Seattle 60
Lawrence 58
Princeton 58
San Mateo 57
Cambridge 53
Lauterbourg 53
Milan 49
Moscow 49
Hefei 44
Centro 33
São Paulo 32
Marche 31
Ottawa 28
Munich 27
Turin 24
Buffalo 21
Helsinki 21
Redmond 20
Brussels 19
Da Nang 19
Orem 17
Rome 17
San Diego 17
Haiphong 16
Ancona 15
Tokyo 15
Chicago 14
Poplar 13
London 12
Santa Clara 12
Guangzhou 11
Montreal 11
Washington 11
Boston 10
Tampa 10
Warsaw 10
Chennai 9
Columbus 9
Mexico City 9
Nuremberg 9
Brasília 8
Dhaka 8
Manchester 8
Salt Lake City 8
Turku 8
Belo Horizonte 7
Brooklyn 7
Curitiba 7
Denver 7
Elk Grove Village 7
Frankfurt am Main 7
Norwalk 7
Porto Alegre 7
Wuhan 7
Atlanta 6
Biên Hòa 6
Hải Dương 6
Jakarta 6
Johannesburg 6
Padova 6
Ribeirão Preto 6
San Francisco 6
Shanghai 6
Tashkent 6
Trieste 6
Amman 5
Amsterdam 5
Bogotá 5
Can Tho 5
Naples 5
Phoenix 5
Quận Ba 5
Rio de Janeiro 5
Seoul 5
Tolentino 5
Vienna 5
Wellington 5
Ankara 4
Totale 6.262
Salva come PNG Salva come JPEG
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.227
Circulating inflamma-miRs in aging and age-related diseases. 809
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease 230
Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas. 212
Cytotoxic and genotoxic potential of asbestos fibers from environmental outcrops 212
Cytotoxicity in vitro of two non-commercial samples of chrysotile and fibrous erionite 204
Activation of transcription factors STAT1 and STAT5 in the mouse median eminence after systemic ciliary neurotrophic factor administration 202
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 199
In Vitro H2O2 Stress And Patterns Of Mitochondrial Damage In The Nctc 2544 Continuous Cell Line 196
Fisiopatologia degli organi emopoietici e del sangue 184
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 170
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas 167
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. 157
Asbestos induced toxicity: in vitro different effects of different fibres. 155
A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired 152
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 150
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. 147
Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase 145
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes 145
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 144
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. 141
The Experimental Pathology at Ancona: 50 Years of Exciting and Pioneering Research on Human Pathology 139
The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. 138
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. 135
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. 132
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 131
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. 129
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. 127
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 123
miR-132–3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer’s disease 122
Sex/gender-related differences in inflammaging 122
erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. 122
Cancerogenesi chimica e fisica 121
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. 120
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 119
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 118
eps15, a novel tyrosine kinase substrate, exhibits transforming activity. 115
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. 113
A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells 113
Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. 112
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study. 111
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 106
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 106
Polynucleotide and substrate for the epidermal growth factor receptor kinase (EPS8) 103
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. 102
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: a comprehensive model inspiring asbestos-induced cancer prevention strategies 100
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing. 100
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 100
DNA encoding human and murine EPS15, a substrate for the epidermal growth factor receptor 99
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 96
uPAR mimicking peptides 91
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER 90
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 88
In Vitro H202 stress and patterns of mitochondrial damage in the NCTC 2544 Continuous cell line- a morphological and morphometric study. 87
Serum soluble urokinase-type plasminigen activator receptor (Supar) is a useful marker of prostate cancer 85
Survivin detection in saliva samples from patient with oral squamous cell carcinoma 83
Purification of tyrosine phosphorylated proteins by immunoaffinity chromatography and direct cloning of their cDNAs from bacterial expression libraries 73
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. 72
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells 70
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? 68
PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma 66
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. 59
Totale 10.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022447 24 94 2 21 10 29 18 36 33 40 52 88
2022/20231.179 77 109 80 98 83 357 2 63 217 6 61 26
2023/2024585 88 15 35 98 92 123 7 14 2 28 15 68
2024/20251.134 163 86 68 8 42 24 120 58 224 118 102 121
2025/20265.556 248 559 1.124 315 271 231 620 259 1.525 202 118 84
Totale 10.654